|
GTF2A2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.232600E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.978210E-03 |
| Normal-vs-Stage2 |
3.097700E-02 |
| Normal-vs-Stage3 |
6.521200E-03 |
| Normal-vs-Stage4 |
2.931400E-01 |
| Stage1-vs-Stage2 |
9.748200E-01 |
| Stage1-vs-Stage3 |
6.797000E-01 |
| Stage1-vs-Stage4 |
3.909600E-01 |
| Stage2-vs-Stage3 |
7.444600E-01 |
| Stage2-vs-Stage4 |
4.668400E-01 |
| Stage3-vs-Stage4 |
2.962800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.171100E-04 |
| Normal-vs-AfricanAmerican |
1.779760E-02 |
| Normal-vs-Asian |
4.213800E-01 |
| Caucasian-vs-AfricanAmerican |
2.988000E-01 |
| Caucasian-vs-Asian |
4.548200E-01 |
| AfricanAmerican-vs-Asian |
6.987000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.59330000000435E-05 |
| Normal-vs-Female |
8.932200E-02 |
| Male-vs-Female |
3.412300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.109700E-02 |
| Normal-vs-Extreme_Weight |
3.004900E-03 |
| Normal-vs-Obese |
1.735930E-03 |
| Normal-vs-Extreme_Obese |
1.162340E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.675800E-01 |
| Normal_Weight-vs-Obese |
2.540200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.096400E-01 |
| Extreme_Weight-vs-Obese |
5.376400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.759200E-01 |
| Obese-vs-Extreme_Obese |
4.749800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.378100E-02 |
| Normal-vs-Age(41-60Yrs) |
1.426240E-02 |
| Normal-vs-Age(61-80Yrs) |
1.413800E-04 |
| Normal-vs-Age(81-100Yrs) |
3.117600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.658400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.440600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.882030E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.210200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.430980E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.207600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.298400E-03 |
| Normal-VS-Type2 PRCC |
4.22749999995364E-06 |
| Normal-VS-KIRP CIMP |
1.232780E-01 |
| Normal-VS-Unclassified PRCC |
6.12859999999937E-05 |
| Type1 PRCC-VS-Type2 PRCC |
2.447500E-04 |
| Type1 PRCC-VS-KIRP CIMP |
8.613800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.899000E-03 |
| Type2 PRCC-VS-KIRP CIMP |
1.620360E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.436000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.518820E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.5475000000047E-05 |
| Normal-vs-N1 |
4.964400E-02 |
| Normal-vs-N2 |
1.940240E-01 |
| N0-vs-N1 |
1.194960E-01 |
| N0-vs-N2 |
7.495600E-01 |
| N1-vs-N2 |
7.160800E-01 |
|
|
